Omnicell Earnings: Here’s Why Investors are Not Happy Now

Omnicell Inc. (NASDAQ:OMCL) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 1.48%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Omnicell Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased 61.54% to $0.21 in the quarter versus EPS of $0.13 in the year-earlier quarter.

Revenue: Rose 35.81% to $87.11 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Omnicell Inc. reported adjusted EPS income of $0.21 per share. By that measure, the company beat the mean analyst estimate of $0.19. It missed the average revenue estimate of $87.2 million.

Quoting Management: “Our overall results exceeded expectations for the first quarter of 2013,” said Randall Lipps, Omnicell president, chairman and CEO. “Organizationally, we’ve taken important steps toward optimizing the growth opportunities in medication management across the spectrum of healthcare settings from hospitals to long term care to home care. We believe these actions and our solid performance this quarter positions the company for a strong fiscal 2013.”

Key Stats (on next page)…

More Articles About:   , , , ,